ATHIRA PHARMA INC (ATHA)
US04746L1044 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 90.58M | 96.00M | 110.50M | 60.60M | 2.10M | |||
| Marketable Securities | 56.84M | 104.40M | 143.20M | 124.10M | 0.00 | |||
| Receivables | 1.63M | 1.20M | 2.30M | 1.30M | 0.00 | |||
| Other Current Assets | 5.68M | 6.00M | 4.70M | 6.40M | 100.00K | |||
| Total Current Assets | 154.73M | 207.50M | 260.80M | 192.30M | 2.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.44M | 5.30M | 5.20M | 3.60M | N/A | |||
| Investments And Advances | 0.00 | 44.80M | 65.90M | 83.50M | N/A | |||
| Other Non-Current Assets | 1.08M | 500.00K | 100.00K | 100.00K | N/A | |||
| Total Non-Current Assets | 5.52M | 50.70M | 71.20M | 87.30M | 0.00 | |||
| TOTAL ASSETS | 160.25M | 258.20M | 332.00M | 279.60M | 2.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 28.71M | 18.90M | 8.70M | 3.20M | 900.00K | |||
| Accounts Payable | 129.00K | 2.50M | 600.00K | 1.20M | 400.00K | |||
| Other Current Liabilities | 28.84M | N/A | 9.29M | N/A | N/A | |||
| Total Current Liabilities | 28.84M | 21.40M | 9.30M | 4.40M | 1.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.60M | |||
| Other Non-Current Liabilities | 1.22M | 1.60M | 1.60M | 900.00K | 2.00M | |||
| Total Non-Current Liabilities | 1.22M | 1.60M | 1.60M | 900.00K | 3.60M | |||
| TOTAL LIABILITIES | 30.06M | 23.00M | 10.90M | 5.30M | 4.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -309.21M | -191.50M | -95.90M | -41.00M | -21.10M | |||
| Additional Paid In Capital | 439.74M | 428.60M | 417.40M | 315.30M | 1.40M | |||
| Common Shares | 4.00K | 0.00 | 0.00 | 0.00 | 17.10M | |||
| Other Shareholders' Equity | -349.00K | -2.00M | -400.00K | 0.00 | N/A | |||
| Shares Outstanding | 38.17M | 37.90M | 37.40M | 32.50M | 30.80M | |||
| Tangible Book Value per Share | 3.41 | 6.20 | 8.59 | 8.44 | -0.64 | |||
| Total Shareholders' Equity | 130.19M | 235.10M | 321.10M | 274.30M | -2.70M | |||
| TOTAL LIABILITIES AND EQUITY | 160.25M | 258.20M | 332.00M | 279.60M | 2.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -0.59 | |||
| Current Ratio | 5.37 | 9.70 | 28.04 | 43.70 | 1.69 | |||
| Return On Assets (ROA) | -73.43% | -37.04% | -16.52% | -7.14% | -234.55% | |||
| Return On Equity (ROE) | -90.39% | -40.68% | -17.08% | -7.28% | N/A | |||
All data in USD